MYH8: Myosin Heavy Chain 8

A sarcomeric myosin gene associated with Carney complex and trismus-pseudocamptodactyly syndrome

Gene Information Card

Symbol MYH8
Full Name myosin heavy chain 8
Gene Type protein-coding
Chromosomal Location 17p13.1
NCBI Gene ID 4626 ncbi.nlm.nih.gov/gene/4626
Ensembl ID ENSG00000133019
UniProt ID P13535
OMIM ID 160742
HGNC ID 7578
Aliases MyHC-perinatal, MyHC-2B, MYH8A

Description

MYH8 encodes a member of the myosin heavy chain family, specifically the perinatal isoform of skeletal muscle myosin. This protein is a major component of the sarcomere, essential for muscle contraction. Mutations in MYH8 are associated with Carney complex variant (familial cardiac myxoma) and trismus-pseudocamptodactyly syndrome (Hecht syndrome).

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Carney complex variant Gain-of-function mutations in MYH8 lead to altered myosin ATPase activity, promoting cardiac myxoma formation PMID: 15121796, ClinVar
Trismus-pseudocamptodactyly syndrome (Hecht syndrome) Dominant-negative mutations disrupt perinatal myosin function, causing muscle contractures and limited mouth opening PMID: 15121796, OMIM #158300

Expression Profile

Tissue Expression
Tissue nTPM level
Skeletal muscle 58.2 High
Heart 12.4 Medium
Esophagus 8.1 Medium
Thyroid 0.9 Low
Brain 0.2 Not detected
Cell Line Expression
Cell Line nTPM Notes
LHCN-M2 (myoblast) 45.6 High expression in differentiated myotubes
HSMM (skeletal muscle cells) 52.1 High expression
A549 (lung) 0.3 Not detected
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.2027G>A (p.Arg676His) Missense Rare Gain-of-function; associated with Carney complex
c.2021G>A (p.Arg674Gln) Missense Rare Dominant-negative; associated with trismus-pseudocamptodactyly syndrome
c.2021G>C (p.Arg674Pro) Missense Rare Dominant-negative; associated with trismus-pseudocamptodactyly syndrome
Mutation functional classification

Loss of Function (LOF)

Not reported for MYH8; loss-of-function likely embryonic lethal in humans.

Gain of Function (GOF)

p.Arg676His increases myosin ATPase activity, leading to hypercontractility and cardiac myxoma.

Dominant Negative (DN)

p.Arg674Gln and p.Arg674Pro disrupt perinatal myosin function, causing muscle contractures.

Pathways

R-HSA-397014 – Muscle contraction
R-HSA-445355 – Smooth muscle contraction
R-HSA-390522 – Striated muscle contraction

Protein Summary

Myosin heavy chain 8 (MYH8) is a 1936-amino-acid sarcomeric myosin expressed predominantly in perinatal skeletal muscle and adult fast-twitch fibers. It forms the thick filament of the sarcomere and converts chemical energy from ATP hydrolysis into mechanical force for muscle contraction. Mutations in the motor domain (e.g., p.Arg674Gln) cause dominant-negative effects leading to trismus-pseudocamptodactyly syndrome, while p.Arg676His confers gain-of-function associated with Carney complex.

Related Products

Product name Cat.No. Species Gene ID
MYH8 Knockout HEK293 Cell Line EDJ-KQ4502 Human 4626 Details Get a Quote
MYH8 Knockout HeLa Cell Line EDJ-KQ53943 Human 4626 Details Get a Quote
MYH8 Knockout A-549 Cell Line EDJ-KQ62435 Human 4626 Details Get a Quote
MYH8 Knockout HCT 116 Cell Line EDJ-KQ70902 Human 4626 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: